FDA
approval
· 2020-01-02
FDA Approved: NEVIRAPINE — Supplemental Application (Amneal Pharmaceuticals LLC)
Summary
The FDA approved a supplemental application for Amneal Pharmaceuticals LLC's nevirapine product, updating an already approved generic antiretroviral.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NEVIRAPINE (NEVIRAPINE)